iRGD-PLGA Nanocomplex Targets Chemoresistant Colon Cancer
Researchers engineered PLGA nanocomplexes functionalized with iRGD tumor-penetrating peptides to deliver paclitaxel combined with medicinal fungus extract, targeting the PDCD4 gene to overcome drug resistance.